Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans
ConclusionOlder age was associated with loss to care, especially among those with slow efavirenz metabolism. Understanding the relationship between older age and CYP2B6 genotype will be important to improving outcomes in an aging population initiating efavirenz-based ART in similar settings.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: African Health | Botswana Health | Brain | Drugs & Pharmacology | Neurology | Study | Toxicology